ClearGuard HD™

Antimicrobial Barrier Caps for Hemodialysis Catheters

Clinically proven to reduce the rate of CLABSIs in hemodialysis catheter patientsReduce hemodialysis catheter
infections with clinically
proven technology
1,2Catheter infections are frequent, costly, and deadly
Catheters cause 70% of vascular access-related BSIs and central venous catheters are used in only 19% of all dialysis
procedures in the United States. Not only are central line-associated bloodstream infections (CLABSIs) a leading cause ofhospitalization and the second leading cause of death in hemodialysis patients but they also increase healthcare costs by anaverage of $48,108 per infection.3,4,5

Reduce hemodialysis catheter infections by up to 63%

1Multiple large, prospective, cluster-randomized multicenter open-label trials demonstrated a significant reduction in the rate ofpositive blood cultures (PBCs) and CLABSIs using ClearGuard HD caps vs. control groups.

Recommended in Infusion
Therapy Standards of Practice
9th edition: 2024
INS SOP, 27. Vascular Access andHemodialysis, Section C3
INS SOP, 47. Vascular Access DeviceRelated Infection, Section JRecommendedin the UKs NICE
Medical Technologies
Guidance[MTG62]

Special Report publishedby Global Business Media
exclusively features
ClearGuard HD
Titled: Reducing Catheter Related
Bloodstream Infections in
Hemodialysis Patients

Recommended in the UKs NICE National
Guidance for hemodialysis catheterrelated bloodstream infections: 2021**
https://www.nice.org.uk/guidance/mtg62/

Recommended in NKF’s KDOQI Clinical
Practice Guideline for Vascular Access: 20196
21.3 KDOQI considers it reasonable to use an
antimicrobial barrier cap to help reduce CRBSI inhigh-risk patients or facilities; the choice of connector
should be based on clinician’s discretion and best
clinical judgment. (Expert Opinion)

A simple, intuitive design
The ClearGuard HD antimicrobial barrier cap is the first and only device for sale designed to kill infection-causing
bacteria inside a hemodialysis catheter hub.* ClearGuard HD features a rod that extends into the hemodialysis catheter
hub. The rod and cap threads are coated with chlorhexidine, a well-known broad-spectrum antimicrobial agent.
*Designed to kill microorganisms, not intended to be used for treatment of existing infections.

Contact us today to find out how ClearGuard HD can play a large role in yourinfection control practices. Visit www.icumed.com or call 866.488.6088
1. Brunelli, SM et al. Cluster-randomized trial of devices to prevent catheter-related bloodstream infection. J Am Soc Nephrol. 2018 Apr,29(4):1336-1343. 2. Hymes, JL et al. Dialysis catheter-related bloodstream
infections: a cluster-randomized trial of the ClearGuard HD antimicrobial barrier cap. Am J Kidney Dis. 2017 Feb;69(2)220-227. 3. Nguyen OB, Shugart A, Lines C, Shah AB, Edwards J, Pollock D, Sievert D,Patel PR. National healthcare safety network (NHSN) dialysis event surveillance report for 2014. Clin J Am Soc Nephrol 12(7), 1139-1146, 2017. 4. United States Renal Data System. 2018 USRDS annual report:
Epidemiology of kidney disease in the Unites States. National Institutes of Health, Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 2018. 5. Results. Content last reviewed November 2017. Agency
for Healthcare Research and Quality, Rockville, MD. https://www.ahrq.gov/hai/pfp/haccost2017-results.html 6. Lok CE, Huber TS, Lee T, et al; KDOQI Vascular Access Guideline Work Group. KDOQI clinicalpractice guideline for vascular access: 2019 update. Am J Kidney Dis. 2020;75(4)(suppl 2):S1-S164.
** © NICE 2021 ClearGuard HD antimicrobial barrier caps for preventing haemodialysis catheter-related bloodstream infections. Medical technologies guidance [MTG62]. Available from https://www.nice.org.
uk/guidance/mtg62/chapter/1-Recommendations All rights reserved. Subject to Notice of rights NICE guidance is prepared for the National Health Service in England. All NICE guidance is subject to regularreview and may be updated or withdrawn. NICE accepts no responsibility for the use of its content in this product/publication.

© 2024 ICU Medical, Inc. |P24-4778|

For safe and proper use, refer to the Instructions for Use.

800.824.7890 |

www.icumed.com